Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/3997
Title: | Should hydrogen therapy be included in a musculoskeletal medicine routine? | Authors: | Ostojić, Sergej | Keywords: | FDA;Molecular hydrogen;Rheumatoid arthritis;Soft tissue injury | Issue Date: | 10-Nov-2016 | Journal: | F1000Research | Abstract: | Molecular hydrogen (H2) has recently been recognized as a potential novel therapeutic agent in biomedicine. Initially proposed to be a possible treatment for certain types of neuromuscular disorders, cardio-metabolic diseases and cancer, H2 improved clinical end-points and surrogate markers in several clinical trials, mainly acting as an anti-inflammatory agent and powerful antioxidant. In this paper, the medicinal properties of H2 in musculoskeletal medicine are discussed with the aim to provide an updated and practical overview for health professionals working in this field. | URI: | https://open.uns.ac.rs/handle/123456789/3997 | ISSN: | 2046-1402 | DOI: | 10.12688/f1000research.9758.1 |
Appears in Collections: | FSFV Publikacije/Publications |
Show full item record
SCOPUSTM
Citations
5
checked on May 10, 2024
Page view(s)
19
Last Week
9
9
Last month
0
0
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.